Sivik Global Healthcare’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
+6,500
| New | +$2.12M | 0.58% | 35 |
|
|
2025
Q1 | – | Sell |
-7,000
| Closed | -$1.65M | – | 32 |
|
|
2024
Q4 | $1.65M | Buy |
+7,000
| New | +$1.65M | 0.87% | 33 |
|
|
2023
Q3 | – | Sell |
-8,000
| Closed | -$1.52M | – | 35 |
|
|
2023
Q2 | $1.52M | Buy |
8,000
+500
| +7% | +$95K | 0.36% | 38 |
|
|
2023
Q1 | $1.5M | Buy |
+7,500
| New | +$1.5M | 0.65% | 40 |
|